Dr. Eric J. Lenze, MD

Dr. Lenze practices at Washington University School of Medicine in Saint Louis, Missouri.

Dr. Lenze's NPI, 1619941846, was assigned on February 15, 2006. Dr. Lenze graduated from WashU Medicine in 1994. Dr. Lenze holds Missouri license 2007029603.

Dr. Lenze's primary practice is Washington University School of Medicine, at 216 S Kingshighway Blvd, Saint Louis, MO 63110 in Saint Louis City. The practice phone is (314) 362-5184.

Dr. Lenze's primary practice is Washington University School of Medicine in Saint Louis, Missouri. Dr. Lenze is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Lenze to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lenze practices, 4 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Lenze's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Lenze is board certified in geriatric psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Lenze's licenses on file in 3 states: Missouri, Illinois and Pennsylvania.

Dmand AI lists adjustment disease, anxiety, bipolar disorder, depression, non-alzheimer's dementia (chronic) and schizophrenia among the conditions Dr. Lenze treats.

CMS data shows 475 Medicare services from Dr. Lenze across 4 procedure codes in 2024, for 161 Medicare patients. Medicare paid $36,386 for them. Every service was in an office.

CMS counts 161 Medicare patients who saw Dr. Lenze in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have depression, and 75% have high cholesterol. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lenze's median patient age at 76, with 63% women.

In 2024, Dr. Lenze wrote 1,686 Medicare Part D claims for 268 patients. 93% of them were for generic drugs. CMS names the drug for 1,510 of them, across 32 drugs with 11 or more claims each, at $43,977 in total drug cost. In 2023, CMS named 1,383 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Lenze for performance year 2024, reported as part of a group. Dr. Lenze accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lenze as offering telehealth.

Dmand AI links 249 papers to Dr. Lenze, published from 2008 to 2025. 2023 was the busiest year, with 25. The most frequent topics are Depressive Disorder, Major, Depression and Antidepressive Agents. Dr. Lenze has published most often in Am J Geriatr Psychiatry. Dr. Lenze's most frequent co-authors are Jordan F. Karp, MD, Ginger Ellen Nicol, MD and Carmen Andreescu, MD.

Dmand AI links Dr. Lenze to 23 clinical trials, 8 of them phase 4 studies. 1 is still active or recruiting. Conditions studied include Anxiety Disorders, Depression and Depressive Disorder, Major. Washington University School of Medicine sponsors the most, 14. Open Payments lists research payments to Dr. Lenze that name 3 trials.

CMS Open Payments shows 57 general payments to Dr. Lenze from 9 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 82% of the total. Janssen Research & Development, LLC paid the most, $23,444. It also lists 3 research payments totaling $23,400 from 2017 to 2018, naming 3 clinical trials.

Dmand AI lists 1 award for Dr. Lenze, most recently CMS Stage 1 EHR in 2012.

Dr. Lenze graduated from WashU Medicine in 1994.

Dr. Lenze is in network with 10 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.